CBC isolate

  • CBC isolate


Purity >98%

CBC (Cannabichromene) is a market trending  minor cannabinoid. It is a rather exquisite molecule due to it’s chromene bicyclic ring system, which is absent in other commonly found cannabinoids.

In hemp and it’s extracts CBC is found in low concentration, this in combination with complicated separation makes CBC hardly affordable at large quantities. However, our proprietary  technology allows us to achieve large amounts of  this minor cannabinoid exceeding 98% purity.

Contact UsBook a CallGet a sample

If you want to join our satisfied clients – be sure to contact us or book a call!



Origin Synthetic
Appearance Amber-Brown
Consistency Liquid
Purity >98%

CBC Isolate

Introducing Cannabichromene, a compound which, amongst other things, demonstrates anti tumour properties.
If this alone doesn’t justify giving some more attention to minor cannabinoids, then we don’t know what will.
How about the fact that CBC cannabinoid can be taken in various forms?
Consumers can choose to take Cannabichromene (CBC) as CBC isolate, CBC oil, CBC pills, or even as CBC extract.
Whatever form people decide to take the CBC in though, and for whatever use (such as CBC for pain or CBC for acne) they can be sure that this is backed up by decades of research and development, with plenty more decades of further research and development still to come.
CBC cannabinoid was one of the first minor cannabinoids to be isolated from the cannabis plant when it was discovered more than 50 years ago. To many, it is considered one of the ‘big six’ in cannabinoids in the world of research and development.
One of Sanobiotec co-founders, Rytis V. Urbonas reports that CBC was actually considered a major cannabinoid at first, due to what seemed like a large abundance. Then came the realisation that for many years, the actual findings had been a CBC-CBD complex and that CBC only constitutes about 0.2% of the dry weight of a typical plant.
Needless to say, CBC was then reclassified as a minor cannabinoid.

cbc cannabinoid

Recent Relevant Research

There are plenty of reasons why we’re interested in CBC isolate, including some promising research that explores if:

  • CBC has significant potential as an antidepressant;
  • Similarly to CBD, CBC inhibits nociceptive signalling and could reduce pain;
  • CBC has been validated as an anti inflammatory, especially in the gastrointestinal tract;
  • CBC demonstrates anti tumour properties;
  • CBC has the potential to be used as an antibacterial, acne medication and for migraine therapy.

We’re always looking into new ways to utilise minor cannabinoids, and CBC is front and centre of our research efforts. This is mirrored globally too, and recent research with CBC has focused on trying to identify its effectiveness for:

  • Antibacterial purposes
  • Acne
  • Anti inflammation
  • Analgesia (pain relief)
  • Antidepressant
  • Neurogeneration
  • Epilepsy
  • Cancer
  • Irritable Bowel Syndrome (IBS)

The eyes of the world are looking to minor cannabinoids more than ever, and at cannabichromene in particular, with researchers and consumers alike now taking it very seriously and paying closer attention to this compound. It follows that an increase in interest leads to an interest in demand, especially when the potential is seemingly limitless.
Fortunately, Sanobiotec is ready to meet that demand head-on, producing CBC of the highest quality, and at scale.
We know that brands who use cannabinoids for their products, and consumers further along the chain, are keen to see the benefits of minor cannabinoids like CBC for themselves. They might try CBC in the form of CBC isolate oil, or even choose to take CBC pills, that’s up to them.
Producing the very best CBC isolate as an ingredient for our partners to use for every application and purpose. That’s up to us.

This a summary of research interests for each cannabinoid being discussed. These statements have not been evaluated by regulatory bodies such as Food and Drug Administration. This ingredient is not intended to diagnose, treat, cure or prevent any disease. Sanobiotec has provided this summary solely to provide the reader with information on the types of studies being conducted on cannabinoids.

1. Appendino G, Gibbons S, Giana A, et al. Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. J Nat Prod. 2008;71(8):1427-1430. doi:10.1021/np8002673
2. Anderson LL et al. Cannabichromene, related phytocannabinoids, and 5-fluoro-cannabichromene have anticonvulsant properties in a mouse model of Dravet syndrome. ACS Chem Neurosci. January 2021; 12(2): 330-339.
3. Anis O et al. Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization. Molecules. January 2021; 26(2): 465. doi:10.3390/molecules26020465
4. De Petrocellis et al. Effects of cannabinioids and cannabinoid enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Brit J Pharmacol 2011 Aug; 163 (7):1479. doi.org/10.1111/j.1476-5381.2010.01166.x
5. El-Alfy A et al. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa LPharmacol Biochem Behav. June 2010;95(4):434-442. doi:10.1016/j.pbb.2010.03.004
6. Izzo AA et al. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol. 2012;166(4):1444-1460. doi:10.1111/j.1476-5381.2012.01879.x
7. Maione et al. Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action.  95(4): 434-442. J Pharmacol. February 2011; 162(3): 584-596.
8. Leimuranta P, Khiroug L, Giniatullin R. Emerging Role of (Endo)Cannabinoids in Migraine. Front Pharmacol. 2018;9:420. Published 2018 Apr 24. doi:10.3389/fphar.2018.00420
9. Olah et al. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Exp Dermatol. September 2016; 25(9):701-707.
10. Romano B et al. Br J Pharmacol. May 2013; 169(1):213-229. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis.
11. Shinjyo N and De Marzo V. The effect of cannabichromene on adult neural stem/progenitor cells. Neurochm Int. Nov 2013; 63(5): 432-437.
12. Turner CE and Elsholy MA. Biological activity of cannabichromene, its homologs and isomers.J Clin Pharmacol. August-September 1981; 21(S1)283S-291S.
13. Udoh et al. Cannabichromene is a cannabinoid CB2 receptor agonist.Br J Pharmacol. December 2019; 176(23):4537-4547.
14. Wirth PW et al. Anti-inflammatory properties of cannabichromene.Life Sci. 1980 Jun 9;26(23):1991-5.